-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

803.O1.6 803. Emerging Diagnostic Tools and Techniques I

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
AML, Biological, antibodies, Adult, ALL, apoptosis, Leukemia, CML, Diseases, Non-Biological, CMML, Therapies, Combinations, MDS, B-Cell Lymphoma, MPN, enzyme inhibitors, Biological Processes, white blood cells, T-Cell Lymphoma, Technology and Procedures, Plasma Cell Disorders, Cell Lineage, Lymphoid Malignancies, Study Population, Myeloid Malignancies, Clinically relevant, genetic profiling, genomics, Quality Improvement , flow cytometry, molecular testing, NGS
Sunday, December 6, 2020: 9:30 AM-11:00 AM
Moderators:
Annette S. Kim, MD, PhD, Brigham and Women's Hospital and William Brian Dalton, MD, PhD,
Disclosures:
No relevant conflicts of interest to declare.
9:30 AM

Christoph Kornauth1*, Tea Pemovska, PhD, MSc, BSc1,2*, Gregory Ian Vladimer, PhD3*, Günther Bayer4*, Michael Bergmann5*, Sandra Eder6*, Ruth Eichner2,7*, Harald Esterbauer, MD, PhD8*, Ruth Exner5*, Verena Felsleitner-Hauer9*, Maurizio Forte, MSc1*, Alexander Gaiger1*, Hildegard T. Greinix, MD10, Wolfgang Gstöttner11*, Marcus Hacker12*, Alexander Hauswirth, MD1*, Tim Heinemann13*, Daniel Heintel14*, Mir Ali Reza Hoda15*, Ulrich Jaeger, MD1,16, Lukas Kazianka, MD1*, Lukas Kenner, MD4*, Barbara Kiesewetter, MD17*, Nikolaus Krall, PhD3*, Trang Le, BSc1*, Simone Lubowitzki1*, Marius E Mayerhoefer18,19*, Elisabeth Menschel20*, Olaf Merkel, PhD4*, Katsuhiro Miura, MD, PhD21*, Leonhard Muellauer, MD, PhD4*, Peter Neumeister, MD10*, Thomas Noesslinger, MD20, Katharina Ocko22*, Leopold Öhler23*, Michael Panny, MD20*, Alexander Pichler, MD1*, Edit Anna Porpaczy, MD1*, Gerald Prager, MD17*, Markus Raderer17*, Robin Ristl24*, Reinhard Ruckser, MD25, Julius Salamon26*, Ana-Iris Schiefer4*, Ann-Sofie Schmolke, MD1*, Ilse Schwarzinger, MD8*, Edgar Selzer27*, Cathrin Skrabs1*, Wolfgang R. Sperr, MD1*, Ismet Srndic, MSc2*, Renate Thalhammer, MD8*, Peter Valent, MD1,28, Emiel Van Der Kouwe1*, Katrina Vanura, PhD1, Stefan Vogt9*, Cora Waldstein27*, Dominik Wolf, Univ. Prof. Dr.29, Christoph Zielinski30*, Ingrid Simonitsch-Klupp, MD4*, Giulio Superti-Furga, PhD2*, Berend Snijder, PhD13* and Philipp B. Staber, MD, PhD1

1Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
2CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
3Allcyte, Vienna, Austria
4Department of Pathology, Medical University of Vienna, Vienna, Austria
5Department of Surgery, Medical University of Vienna, Vienna, Austria
6Department of Internal Medicine and Hematology/Oncology, Klinikum Klagenfurt, Klagenfurt, Austria
7Department of Medicine III, Technical University of Munich, Munich, Germany
8Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
9Department of Medicine and Oncology, LKH Wiener Neustadt, Wr. Neustadt, Austria
10Department of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria
11Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna, Austria
12Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria
13Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, Zürich, Switzerland
14Division of Medicine I, Wilhelminenspital, Vienna, Austria
15Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria
16Austrian Group Medical Tumor Therapy, Salzburg, Austria
17Department of Medicine I, Division of Oncology, Medical University Vienna, Vienna, Austria
18Dept. of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, Austria
19Department of Radiology, Memorial Sloan Kettering Cancer Center, New York
203rd Medical Department, Hematology & Oncology, Hanusch Hospital, Vienna, Austria
21Nihon university school of medicine, Tokyo, Japan
22Pharmacy Department, Vienna General Hospital, Vienna, Austria
23Internal Medicine I, Department of Oncology, St. Josef Hospital, Vienna, Austria
24Section for Medical Statistics, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University Vienna, Vienna, Austria
252. Medical Department, SMZ Ost, Vienna, Austria
26Department of Medicine, Landesklinikum Waidhofen a.d. Ybbs, Waidhofen-Ybbs, Austria
27Department of Radiation Oncology, Medical University Vienna, Vienna, Austria
28Ludwig Boltzmann Institute for Hematology and Oncology, Vienna, Austria
29Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Austria
30Vienna Cancer Center, Medical University of Vienna, Vienna, Vienna, Austria

9:45 AM

Niroshan Nadarajah1*, Alex Wagner, PhD2*, Rafael Bejar, MD, PhD3, Mark Ewalt, MD4*, Annette S. Kim, MD5*, Michelle M. Le Beau, PhD6, Xiaotu Ma, PhD7*, Manja Meggendorfer, PhD1, Jamile M. Shammo, MD8, Gabriella Ryan9, Alexa J. Siddon, MD10, David P. Steensma, MD11, Matthew J. Walter, MD12, Ahmet Zehir, PhD13*, Jinghui Zhang, PhD14* and Torsten Haferlach, MD1

1MLL Munich Leukemia Laboratory, Munich, Germany
2Nationwide Children’s Hospital, Columbus, OH
3University of California - San Diego, La Jolla, CA
4University of Colorado Anschutz Medical Campus, Aurora, CO
5Boston/Harvard Medical School, Brigham and Women's Hospital, Boston, MA
6University of Chicago Comprehensive Cancer Center, Chicago, IL
7Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN
8Division of Hematology/Oncology, Rush University Medical Center, Chicago, IL
9American Society of Hematology, Washington, DC
10Departments of Laboratory Medicine and Pathology, Yale School of Medicine, Westbrook, CT
11Dana-Farber Cancer Institute, Boston, MA
12Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
13Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
14Department of Computational Biology and Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN

10:00 AM

Nikhil Patkar, MD1*, Anam Fatima Shaikh2,3*, Chinmayee Kakirde1*, Rakhi Salve4*, Prasanna Bhanshe5*, Gaurav Chatterjee, MD1,2,6*, Sweta Rajpal7*, Swapnali Joshi8*, Shruti Chaudhary1*, Rohan Kodgule1*, Dhanlaxmi Lalit Shetty, PhD9,10*, Hasmukh Jain, MD9,11,12,13*, Bhausaheb Bagal, MD, DM14,15,16,17*, Hari Menon, MD11,18, Navin Khattry, MD, DM15,17,19,20*, Manju Sengar, MD, DM9,11,16,21,22, Prashant Tembhare, MD1,23*, Papagudi Ganesan Subramanian, MD1,24* and Sumeet Gujral, MD1*

1Hematopathology Laboratory, Tata Memorial Centre, Mumbai, India
2ACTREC, Tata Memorial Centre, Navi Mumbai, India
3Hematopathology Laboratory, Tata Memorial Centre, ACTREC, Navi Mumbai, India
4CCE-25, Sector 22, Utsav Chowk - CISF Rd, Owe Camp, Kharghar, Maharashtra, Hematopathology Laboratory, TATA Memorial Centre, ACTREC, Navi Mumbai, India
5Tata Memorial Centre, Kharghar, IND
6ACTREC, Tata Memorial Centre, Mumbai, Maharashtra, India
7Hematopathology Laboratory, TATA Memorial Centre, ACTREC, Navi Mumbai, India
8Hematopathology Labortory, Tata Memorial Centre, Mumbai, India
9Adult Hematolymphoid Disease Management Group, Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
10Adult Hematolymphoid Disease Management Group, Department of Medical Oncology, ACTREC, Navi Mumbai, Maharashtra, IND
11Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
12Adult Hematolymphoid Disease Management Group, Department of Medical Oncology, Tata Memorial Center, Mumbai, India
13Adult Hematolymphoid Disease Management Group, Department of Medical Oncology, Tata Medical Centre, Mumbai, India
14Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India
15Homi Bhabha National Institute., Mumbai., India
16Adult hematolymphoid disease management group, Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
17Bone Marrow Transplant Unit, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre., Navi Mumbai., India
18Cytecare cancer centre, Medical Oncology, Bengaluru, India
19BMT unit, Department of Medical oncology, ACTREC., Tata Memorial Centre, Navi Mumbai, India
20Homi Bhabha National University., Mumbai., India
21Adult Hematolymphoid Disease Management Group, Department of Medical Oncology,, Tata Memorial Center, Mumbai, India
22Adult Hematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, Maharashtra, India
23Adult & Pediatric Hematolymphoid Disease Management Group, Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
24Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Mumbai, Maharashtra, India

10:15 AM

Rongqing Pan, PhD1*, Youzhen Wang2*, Shumei Qiu3*, Jeremy Ryan4* and Ensar Halilovic5*

1Dana-Farber Cancer Institute, Houston, TX
2Novartis Institute of Biomedical Research, Oncology Drug Discovery, Cambridge, MA
3Novartis Institutes for Biomedical Research, Cambridge
4Dana-Farber Cancer Institute, Boston, MA
5Novartis Institutes For Biomedical Research, Oncology Drug Discovery, Cambridge, MA

10:30 AM

Ricardo Sanchez1,2*, Juan Manuel de la Rosa3*, Yanira Heredia1,2*, Jaime Carrillo2*, Laura Rufian1,2*, Esther Onecha, PhD3*, Gonzalo Carreño Gomez-Tarragona, MD3*, Chongwu Wang4*, María Linares1*, Jose Sanchez-Pina1*, Inmaculada Rapado, PhD3*, Josep-Maria Ribera5, Rosa Ayala1*, Joaquin Martinez-López1,6* and Santiago Barrio1,2*

1Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
2Altum sequencing Co., Madrid, Spain
3Hematology Department, Hospital Universitario 12 de Octubre,, Madrid, Spain
4Hosea Precision Medical Technology Co., Ltd., Weihai, Shangdong, China
5ICO-Hospital Germans Trias i Pujol, Badalona, Spain
6Department of Hematology, Hospital Universitario 12 de Octubre; H12O-CNIO Haematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain

*signifies non-member of ASH